Completed NA INTERVENTIONAL 1-arm NCT00929266

Cultured Red Blood Cells : Life Span in Vivo Study (GRc2008)

First Pilot Study Evaluating the Life Span of Autologous Cultured Red Blood Cells (cRBC) Generated From Peripheral Stem Cells in Three Healthy Volunteers - Feasibility Study

Sponsor: Etablissement Français du Sang

Conditions Healthy Volunteers

Interventions intravenous injection of labeled cRBC

Updated 5 times since 2017 Last updated: Nov 9, 2012 Started: May 31, 2010 Primary completion: Nov 30, 2011 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy Volunteers, this trial is completed. The trial is conducted by Etablissement Français du Sang and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Etablissement Français du Sang

Data source: Etablissement Français du Sang

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France